Tsung Allan, Stang Michael T, Ikeda Atsushi, Critchlow Nathan D, Izuishi Kunihiko, Nakao Atsunori, Chan Meagan H, Jeyabalan Geetha, Yim John H, Geller David A
Department of Surgery, University of Pittsburgh, PA 15213, USA.
Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1261-8. doi: 10.1152/ajpgi.00460.2005. Epub 2006 Jan 12.
Hepatic ischemia occurs in the settings of trauma, transplantation, and elective liver resections. The initiating events that account for local organ damage are only partially understood. Interferon (IFN) regulatory factor-1 (IRF-1) is a transcription factor that regulates the expression of a number of genes involved in both innate and acquired immunity; however, its function in liver injury is unknown. Therefore, the purpose of this study was to investigate the role of IRF-1 in hepatic ischemia-reperfusion (I/R) injury. In C57BL/6 mice undergoing 60 min of hepatic ischemia, IRF-1 protein expression increased as early as 1 h after reperfusion. IRF-1 knockout mice were significantly protected from hepatic I/R-induced damage compared with their wild-type controls. Hepatic I/R injury resulted in marked activation of the MAP kinase c-Jun NH(2)-terminal kinase (JNK) in wild-type mice but not IRF-1 knockout mice. IRF-1 knockout mice also exhibited significantly lower hepatic expression of TNF-alpha, IL-6, ICAM-1, and inducible nitric oxide synthase (iNOS) mRNA. Adenoviral delivery of IRF-1 into C57BL/6 mice resulted in increased liver damage even without an ischemic insult. This injury was associated with increased JNK activation and hepatic iNOS expression. Because IRF-1 contributed to liver injury, we also examined for inflammatory signals that regulated IRF-1 gene expression in cultured hepatocytes. Whereas IFN-gamma and IFN-beta were strong inducers of IRF-1 mRNA (>10-fold) in a time- and dose-dependent manner, TNF-alpha and IL-1beta also induced IRF-1 mRNA to a lesser extent (2- to 3-fold). IL-6 and lipopolysaccharide had no effect on IRF-1 expression. This study demonstrates that IRF-1 exerts a harmful role in hepatic I/R injury by modulating the expression of multiple inflammatory mediators. We further show that IRF-1-mediated injury involves the activation of JNK and that hepatocellular IRF-1 expression itself is regulated by specific cytokines.
肝缺血发生于创伤、移植和择期肝切除的情况下。导致局部器官损伤的起始事件仅得到部分理解。干扰素(IFN)调节因子-1(IRF-1)是一种转录因子,可调节许多参与先天性和获得性免疫的基因的表达;然而,其在肝损伤中的功能尚不清楚。因此,本研究的目的是探讨IRF-1在肝缺血再灌注(I/R)损伤中的作用。在经历60分钟肝缺血的C57BL/6小鼠中,IRF-1蛋白表达在再灌注后1小时就开始增加。与野生型对照相比,IRF-1基因敲除小鼠受到显著保护,免受肝I/R诱导的损伤。肝I/R损伤导致野生型小鼠中丝裂原活化蛋白激酶c-Jun氨基末端激酶(JNK)显著激活,但IRF-1基因敲除小鼠未出现这种情况。IRF-1基因敲除小鼠还表现出肝组织中肿瘤坏死因子-α、白细胞介素-6、细胞间黏附分子-1和诱导型一氧化氮合酶(iNOS)mRNA的表达显著降低。将IRF-1通过腺病毒载体导入C57BL/6小鼠,即使在没有缺血损伤的情况下,也会导致肝损伤增加。这种损伤与JNK激活增加和肝iNOS表达增加有关。由于IRF-1促成了肝损伤,我们还研究了在培养的肝细胞中调节IRF-1基因表达的炎症信号。虽然干扰素-γ和干扰素-β以时间和剂量依赖的方式强烈诱导IRF-1 mRNA(>10倍),但肿瘤坏死因子-α和白细胞介素-1β也能在较小程度上诱导IRF-1 mRNA(2至3倍)。白细胞介素-6和脂多糖对IRF-1表达没有影响。本研究表明,IRF-1通过调节多种炎症介质的表达在肝I/R损伤中发挥有害作用。我们进一步表明,IRF-1介导的损伤涉及JNK的激活,并且肝细胞IRF-1表达本身受特定细胞因子调节。